Granules India

Granules India Limited is a prominent pharmaceutical company based in Hyderabad, India. Here's a comprehensive overview:

History

• Founding Year: 1984

• Initial Name: Triton Laboratories

• Early Milestones: Triton began producing Paracetamol API at its Bonthapally facility. In 1987, it became the second Indian company, after Dr. Reddy's Laboratories, to export pharmaceutical products to the U.S. In 1991, the company was rebranded as Granules India Limited.

Products and Services

• Core Products: Granules India specializes in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). Key APIs include Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol.

• Product Range: Offers tablets, caplets, press-fit capsules, high potent products, and oncology products.

• Consumer Health Division: Granules Consumer Health (GCH) focuses on large-volume pharmaceutical products.

Global Presence and Customers

• Global Reach: Supplies products to over 300 customers in more than 80 countries.

• Target Markets: Includes the U.S., Canada, and India among others.

• Regulatory Approvals: Holds 87 regulatory approvals.

Facilities and Operations

• Manufacturing Facilities: Located in Hyderabad and Visakhapatnam, India. The Visakhapatnam facility includes units for Oncology and High Potent APIs.

• R&D Center: Established a research and development facility in Virginia, USA, in 2017.

Leadership and Structure

• Chairman and Managing Director: Dr. Krishna Prasad Chigurupati.

• Joint Managing Director and CEO: Dr. Kandiraju Venkata Sita Ram Rao.

Sustainability and Innovation

• Core Values: Focuses on challenging limits, futuristic thinking, customer-centricity, empowering employees, maintaining quality, and environmental stewardship.

• Patents: Has filed several patents, including one for the preparation of amino alcohol derivatives.

Granules India is a vertically integrated pharmaceutical company known for its high-quality products and strong global presence, serving major pharmaceutical companies worldwide.